Remove 2022 Remove Competition Remove Specialization
article thumbnail

Competition is on the horizon for costly narcolepsy treatments

pharmaphorum

But increased competition is on the horizon. In order to bring it to market, a special program called Risk Evaluation and Mitigation Strategy (REMS) had to be put in place, where only eligible patients could access the drug through a very strict process. Competition starts to heat up. Classic treatment options. About the author.

article thumbnail

Major M&A deals on 2023 agenda, says report

European Pharmaceutical Review

Global M&A activity in 2022. The global life sciences mergers and acquisitions (M&A) investment totalled $105 billion in the first 11 months of 2022, with total deal value well down on 2021. EY’s research observed an overall drop in 2022 M&A investment worldwide. Biopharma alone held over $1.4

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Biopharma struggling to find talent with adequate digital skills

European Pharmaceutical Review

A new report by the Association of the British Pharmaceutical Industry (ABPI) has identified the UK biopharma industry is increasingly seeking talent with artificial intelligence (AI) and data skills to maintain competitiveness as digital technology continues to drive innovation. This has spiked from 27 in 2019 to 225 in 2022.

article thumbnail

Pharma Injecting Life into Digital Health Amidst Funding Downturn

MedCity News

The consensus is 2022 was a challenging year for digital health companies. billion in 2022 — down 56% from $40.2 billion in 2022 — down 56% from $40.2 Rather, 2022 represents an overdue correction in the midst of global economic uncertainty after a period of overexuberance and lofty expectations in digital health.

Pharma 123
article thumbnail

It’s Time for Healthcare To Embrace Patient-Friendly Language

MedCity News

Increasingly, it’s a competitive differentiator – and it can help drive clinical improvements. However, it’s a worthwhile endeavor not just for regulatory compliance but also for improving clinical outcomes and standing out in an increasingly competitive marketplace.

Patients 126
article thumbnail

The Value of Precision Livestock Farming (PLF) in 2022

Celeritas

Monitoring and analysis of special and temporal data on cattle location, movement, and interaction can provide benefits such as. The provision of a competitive advantage over other dairy suppliers also plays a major role in the considerations. Checking their current physical condition. Determining which animals are high-performing.

article thumbnail

The Top 10 Clinical Research Companies in the USA

Medico Reach

In 2022, the global clinical research market stands at $63.6 from 2022 to 2027. For that reason, it is also essential to be aware of the most prominent global research organizations that offer vital support with their specialized clinical trial solutions. billion with a CAGR of 11.0% So, let’s begin: 1.